Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EyePoint, Inc.EYPT · Entity 5702 | SVP & Chief Commercial Officer | February 09, 2024 | February 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EyePoint, Inc.
Report date February 09, 2024 · Filed February 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,572 |
Reported balance
After 2024-02-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-02-09 · Exercise / conversion · Acquired 4,967 · Balance 43,572 F1: Includes 643 shares acquired on January 31, 2024 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 48,572 |
Reported balance
After 2024-02-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-02-09 · Exercise / conversion · Acquired 5,000 · Balance 48,572 |
| Common StockSEC Table I · non-derivative | Direct | 46,617 |
Reported balance
After 2024-02-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2024-02-09 · Tax withholding · Disposed 1,955 · Balance 46,617 F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Common StockSEC Table I · non-derivative | Direct | 44,916 |
Reported balance
After 2024-02-09 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2024-02-09 · Tax withholding · Disposed 1,701 · Balance 44,916 F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-02-09 | Direct | 0 |
Reported balance
After 2024-02-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-02-09 · Exercise / conversion · Disposed 4,967 · Balance 0 F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-02-09 | Direct | 5,000 |
Reported balance
After 2024-02-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-02-09 · Exercise / conversion · Disposed 5,000 · Balance 5,000 F4: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 643 shares acquired on January 31, 2024 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022.
F4: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 825 shares acquired on July 31, 2022 and 1,698 shares acquired on January 31,2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 17:52 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 91,655 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-23-000344 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,655 Underlying: Common Stock · 91,655 shares Expires 2033-01-05 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units vested in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,130 | $9.95 | $11,243.50 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,599 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 18:22 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-002137 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-02-09 F5 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,966 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,934 Underlying: Common Stock · 4,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F4 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F3 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. F3 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,473 | $10.13 | $14,921.49 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,624 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:39 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,966 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001412 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 886 shares acquired on July 30, 2021 and 865 shares acquired on January 31,2022 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-21-006809 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:28 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 60,300 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001562180-21-004453 · primarydocument.xml · derivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,300 Underlying: Common Stock · 60,300 shares Expires 2031-02-09 F2 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 17:28 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 14,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004453 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,005 Underlying: Common Stock · 14,900 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,105 Underlying: Common Stock · 4,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,702 | $10.81 | $18,398.62 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,380 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 28, 2021 Filed Mar 2, 2021 19:25 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001819 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,308 shares acquired on July 31, 2020 and 970 shares acquired on January 29, 2021 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 41,050 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,100 Underlying: Common Stock · 41,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 14,060 | $0.76 | $10,643.42 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,990 F1 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 41,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004870 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 18:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 246,250 | $0.00 Strike: $1.29 | $0.00 |
DisclosureSEC source: 0001562180-20-002043 · primarydocument.xml · derivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,250 Underlying: Common Stock · 246,250 shares Expires 2030-02-28 F2 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which begin March 28, 2020 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 18:01 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 123,150 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-002043 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,150 Underlying: Common Stock · 123,150 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. F1 · derivative.expiration_date: The restricted stock units will vest in three equal installments on the following dates: 6.30.2020, 2.28.2021 and 2.28.2022. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 16:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Options (Right to buy) · Derivative | 350,000 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001562180-19-003509 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2029-06-10 F1 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at June 10th, 2020 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.